All In MedTech

Device Trial Radar · NCT06392607

Euclid Phoenix Lens Design Trial 2

Euclid Phoenix Lens Design Trial Part 2

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

89

Actual

Start

May 28, 2024

Primary completion

Sep 8, 2025

Study completion Sep 8, 2025

Sponsor

Lead sponsor
Euclid Systems CorporationNot on our public-company list
Sponsor type
Industry
First posted
Apr 30, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 6 years, up to 35 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Lens wettability and subjective comfort of Euclid orthokeratology lenses with and without an enhanced coating will be compared in 50 children. Axial elongation will be monitored in pediatric patients who qualify and consent.

Conditions

  • Myopia
  • Cornea

Interventions

  • Euclid orthokeratology (standard coating)Device

    Lens with the current coating

  • Euclid orthokeratology (enhanced coating)Device

    Lens with the enhanced coating

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Lens wettabilityTime frame: 12 months

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Cornea and Contact Lens Institute of Minnesota

    Edina, Minnesota

  • Pinecone Vision Center

    Sartell, Minnesota

  • Somerset Eye Care

    North Brunswick, New Jersey

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.